Abstract: A method of displaying an interface for providing a social networking service (SNS) through an anonymous profile, performed by a user terminal, includes displaying a first list of at least one anonymous chatroom created by a user account for an instant messaging service (IMS) using a first region on a first page in an interface for the IMS, displaying a second list of at least one anonymous profile created to be interlinked with the user account using a first region on a second page in the interface for the IMS, and displaying, in response to an input of selecting any one anonymous profile in the second list, an interface for providing the SNS to through the selected anonymous profile.

Abstract: Disclosed are a method for preparing a biomaterial having selectively functionalized tyrosine, a biomaterial having selectively functionalized tyrosine, and a pharmaceutical composition containing same as an active ingredient. The method for preparing a biomaterial to which a compound represented by chemical formula 2 is coupled, of the present invention, allows the compound represented by chemical formula 2 to be selectively coupled, in a high yield in a biomaterial, to tyrosine, which is present on the surface of an aqueous solution such that the coupling thereof to amino acids other than tyrosine does not occur and, when only one tyrosine is present, heterogeneous mixtures are not present and the inherent activity of the biomaterial is maintained, and thus the compound can be effectively used as a pharmaceutical composition containing a biomaterial drug as an active ingredient.

Abstract: The present invention provides a health functional food composition and a pharmaceutical composition for preventing and alleviating depression, both compositions using an extract of Vaccinium bracteatum Thunb. fruits, which are Korean natural resources, so as to be safely usable without toxicity and side effects.

Abstract: In the present invention, data generated from a source unit are distributed to at least one bandwidth; the data distributed to the respective bandwidths are encoded in order to perform an error correction; the encoded data are distributed to at least one antenna; a subcarrier is allocated to the data distributed to the respective antennas, and an inverse Fourier transform is performed; a short preamble and a first long preamble corresponding to the subcarrier are generated; a signal symbol is generated according to a data transmit mode; and a frame is generated by adding a second long preamble between the signal symbol and a data field for the purpose of estimating a channel of a subcarrier which is not used.

Abstract: The present invention relates to a biomarker composition for diagnosing radiation-resistant cancer comprising PMVK as an active ingredient and a method of diagnosing radiation-resistant cancer using the same, and when the PMVK is knocked down, it is confirmed that the survival rate of cancer cells decreases during radiation treatment, and based on this, the possibility as a factor related to radiation therapy resistance to cancer was suggested, and the PMVK can be used as a new target to enhance the effect of radiation therapy on human cancer cells.

Abstract: This disclosure provides a method of preventing, alleviating or treating a condition (i.e., neutropenia) in a subject in need thereof, the condition characterized by compromised white blood cell production in the subject. The method includes administering to the subject a therapeutically effective amount of a protein complex on the same day as a chemotherapy regimen, wherein the protein complex is a modified human granulocyte-colony stimulating factor (hG-CSF) covalently linked to an immunoglobulin Fc region via a non-peptidyl polymer. The non-peptidyl polymer is site-specifically linked to an N-terminus of the immunoglobulin Fc region, and the modified hG-CSF comprises substitutions in at least one of Cys17 and Pro65.

Abstract: The present disclosure relates to a method for preparing a transglucosylated steviol glycoside using a crude enzyme liquid of a Lactobacillus mali strain.

Abstract: Provided is a novel compound derived from allulose and a composition comprising the same and having acid resistance.

Abstract: An ink composition for photonic sintering and a method or producing the ink composition, the ink composition includes: metal nanoparticles comprising a first metal satisfying interaction formula 1; an organic non-aqueous binder; and a non-aqueous solvent. Interaction formula 1 is A1/A2?0.2, where A1/A2 is a ratio, in the x-ray photoelectron spectrum on the surface of the first metal, in which first metal 2p3/2 peak area of the oxide of the first metal (A1) is divided by first metal 2p3/2 peak area of the first metal (A2).

Abstract: The present invention relates to an anti-CD3 antibody and a pharmaceutical composition for cancer treatment comprising same. The antibody according to the present invention has high affinity and specificity for CD3 and thus can be effectively used in cancer prevention or treatment.

Abstract: Disclosed is a method of operating a terminal on which an application for an instant messaging service is installed, the method that displays a first user interface (UI) for switching an input mode in a chatting interface of a chatroom in which a user of the application is participating, based on whether the user is assigned an authority to emphasize a message in the chatroom, switches the input mode from a first mode which is a normal mode to a second mode for emphasizing a message, in response to a user input with respect to the first UI, emphasizes a message input in the second mode for a predetermined period in a predetermined manner, and cancels the emphasizing of the message input in the second mode, when the predetermined time elapses.

Abstract: The present disclosure relates to an ?-aminoamide derivative compound and a pharmaceutical composition containing the same. According to various embodiments of the present disclosure, provided is a therapeutic agent which can overcome the disadvantages of existing drugs used as a MAO-B inhibitor and, specifically, reversibly inhibits MAO-B through a non-covalent bond so as to alleviate or eliminate the side effects of the existing drugs which exhibit a therapeutic effect by irreversibly acting via a covalent bond with MAO-B. Particularly, a new compound having superior stability and efficacy compared to the existing reversible MAO-B inhibitors may be provided.

Abstract: Provided is a thermoplastic resin composition that includes: a first copolymer including an unit derived from an aromatic vinyl-based monomer and an unit derived from a vinyl cyan-based monomer; a second copolymer including an unit derived from an alkyl (meth)acrylate-based monomer, an unit derived from an aromatic vinyl-based monomer, and an unit derived from a vinyl cyan-based monomer; a third copolymer including a conjugated diene-based polymer with an average particle diameter of 0.25 to 0.35 ?m, an unit derived from an aromatic vinyl-based monomer, and an unit derived from a vinyl cyan-based monomer; and a fourth copolymer including a conjugated diene-based polymer with an average particle diameter of 0.05 to 0.15 ?m, an unit derived from an aromatic vinyl-based monomer, and an unit derived from a vinyl cyan-based monomer, and can be used for producing a molded article exhibiting excellent basic properties while being capable of realizing selective transmittance.

Abstract: The present disclosure relates to a method for preparing a transfructosylated steviol glycoside using Arthrobacter-derived microorganisms, a culture thereof, a supernatant of the culture, an extract of the culture, and a lysate of the microorganisms.

Abstract: The present disclosure relates to a composition for producing tagatose comprising a protein having fructose-4-epimerase activity and a method for producing tagatose using the same.

Abstract: A method for preparing Ganoderma lucidum extract using an eco-friendly extraction technique is disclosed. A Ganoderma lucidum extract prepared thereby and a cosmetic composition containing the extract, and their uses are disclosed. The extraction technique use an aqueous cyclodextrin solution alone or in combination with ultrasonic extraction to afford a Ganoderma lucidum extract containing a high concentration of the effective ingredient triterpenoid.

Abstract: The present invention relates to a method for purifying darbepoetin alfa by selectively separating only a structural isoform having a high content of sialic acid from a mixture of structural isoforms of darbepoetin alfa having various contents of sialic acid. Since the method of the present invention is a novel method for purifying darbepoetin alfa which can be conveniently and simply produced, it is possible to remarkably increase productivity due to process efficiency improvement, as well as to yield high purity darbepoetin alfa when mass-producing darbepoetin alfa according to the present invention.

Abstract: Provided is a thermoplastic resin composition that includes: a first copolymer including an unit derived from an aromatic vinyl-based monomer and an unit derived from a vinyl cyan-based monomer; a second copolymer having a refractive index of 1.51 to 1.53 and including an unit derived from an alkyl (meth)acrylate-based monomer, an unit derived from an aromatic vinyl-based monomer, and an unit derived from a vinyl cyan-based monomer; and a third copolymer including a conjugated diene-based polymer with an average particle diameter of 0.05 to 0.15 ?m, an unit derived from an aromatic vinyl-based monomer, and an unit derived from a vinyl cyan-based monomer, and can be used for producing a molded article capable of realizing selective transmittance.

Abstract: The present invention relates to a recombinant strain for producing an allose from a fructose, a composition for producing an allose which produces an allose from a fructose-containing raw material comprising the strain, and a method for preparing an allose using the same.

Abstract: Provided is a sign language recognition system, and the sign language recognition system includes an acquisition unit configured to acquire an electromyogram signal of a user from a sensor measurement device worn around an arm of the user, an extraction unit configured to extract a muscle active section from the electromyogram signal to detect a sign language gesture of the user, a producing unit configured to produce a first feature vector by performing signal processing to the muscle active section, a search unit configured to search a signal corresponding to the first feature vector in a database, and an output unit configured to output a text corresponding to the searched signal.